Results from Part 1 of the Phase 2/3 SIGLEC Trial Assessing AVD-104 for Geographic Atrophy: Glyco-immunologic Modulation of Macrophage Activity

  • Rishi P. Singh, MD
  • Video
  • Published 2024

See more